Revolution Medicines Stock Quote RVMD - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

35.59

Bid

34.90

Ask

36.50

Volume

213

0.00 Day's Range 0.00

15.4401 52 Week Range 38.73

Market Cap

51.054M

Previous Close

35.59

Open

Last Trade

35.08

Last Trade Time

09:29:49

Financial Volume

VWAP

Average Volume (3m)

1,503,302

Shares Outstanding

164,690,408

Dividend Yield

PE Ratio

-0.12

Earnings Per Share (EPS)

-2.65

Revenue

11.58M

Net Profit

-436.37M

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include R... Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.revmed.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Revolution Medicines Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RVMD. The last closing price for Revolution Medicines was $35.59. Over the last year, Revolution Medicines shares have traded in a share price range of $ 15.4401 to $ 38.73.

Revolution Medicines currently has 164,690,408 shares outstanding. The market capitalization of Revolution Medicines is $51.05 million. Revolution Medicines has a price to earnings ratio (PE ratio) of -0.12.

Overall Flow

Bearish

Net Premium

-9k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that exhibits unprecedented anti-tumor activity in...

Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...

Form 4 - Statement of changes in beneficial ownership of securities

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.07	-2.91871249318	36.66	37.87	34.23	1173862	35.7784651	CS
4	4.01	12.6979100697	31.58	38.73	29.55	1395189	34.81142657	CS
12	7.75	27.8376436782	27.84	38.73	27.4	1503302	32.0605523	CS
26	14.46	68.4335068623	21.13	38.73	18	1580637	27.55165955	CS
52	12.45	53.8029386344	23.14	38.73	15.4401	1555046	27.39354141	CS
156	-6.34	-15.1204388266	41.93	43.49	14.08	1057011	25.77319826	CS
260	6.24	21.2606473595	29.35	56.18	14.08	874828	27.28133002	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.3999 (0.00%)	2.07k
AADRAdvisorShares Dorsey Wright ADR ETF	$ 60.2684 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.78 (0.00%)	5.28k
AACIArmada Acquisition Corporation I	$ 11.5001 (0.00%)	1,000
AACGATA Creativity Global	$ 0.87 (0.00%)	841
AAGRAfrican Agriculture Holdings Inc	$ 0.3999 (0.00%)	2.07k
AADRAdvisorShares Dorsey Wright ADR ETF	$ 60.2684 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.78 (0.00%)	5.28k
AACIArmada Acquisition Corporation I	$ 11.5001 (0.00%)	1,000
AACGATA Creativity Global	$ 0.87 (0.00%)	841
SPCBSuperCom Ltd	$ 0.2236 (0.00%)	20.7M
AIREreAlpha Tech Corporation	$ 1.16 (0.00%)	17.65M
SGBXSafe and Green Holdings Corporation	$ 0.1441 (0.00%)	13.65M
SQQQProShares UltraPro Short QQQ	$ 11.81 (0.00%)	11.74M
ILAGIntelligent Living Application Group Inc	$ 0.54 (0.00%)	10.67M